Corporate Board Profile
Tech Score: 100/100
1 mention(s) identify JENNIFER COCHRAN, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 2022-04-22 | Dr. Cochran is a Professor of Bioengineering at Stanford University and was Chief Scientist of Lagunita Biosciences, a healthcare investment company and incubator. She received a Ph.D. in biological chemistry from MIT. | Has a Ph.D. in biological chemistry and extensive bioengineering background; served as Professor of Bioengineering and Chief Scientist at a healthcare investment company, indicating technical expertise relevant to software and programming. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-22 | Dr. Cochran is a Professor of Bioengineering at Stanford University and was Chief Scientist of Lagunita Biosciences, a healthcare investment company and incubator. She received a Ph.D. in biological chemistry from MIT. |
Data sourced from SEC filings. Last updated: 2025-10-12